Serum antibody concentrations of cytotoxin, exotoxin, A, lipopolysaccharide, protease, and elastase and survival of patients with Pseudomonas aeruginosa bacteremia.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Clinical Infectious Diseases

• Publication date

  1996-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/CLINIDS/23.5.1109PMID 8922810
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pseudomonas aeruginosa bacteremia in patients with AIDS.

  1994cited by this paper
• Kendall's Advanced Theory of Statistics.

  1994cited by this paper
• Anti-lipopolysaccharide antibody levels in patients with AIDS at the onset of Pseudomonas aeruginosa bacteremia.

  1994cited by this paper
• Bacteremia due to Pseudomonas aeruginosa in children with AIDS.

  1993cited by this paper
• Immunoglobulin G antibodies toPseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremia

  1993cited by this paper
• [Pseudomonas aeruginosa bacteremia].

  1991cited by this paper
• Purification and characterization of an active fragment of the LasA protein from Pseudomonas aeruginosa: enhancement of elastase activity

  1990cited by this paper
• Oropharyngeal and fecal carriage of Pseudomonas aeruginosa in hospital patients

  1989cited by this paper
• Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients.

  1989cited by this paper
• Oropharyngeal and fecal carriage of Pseudomonas aeruginosa in hospital patients.

  1989cited by this paper
• Pseudomonas aeruginosa cytotoxin: periplasmic localization and inhibition of macrophages

  1989cited by this paper
• Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases

  1988cited by this paper
• Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis

  1988cited by this paper
• The design and analysis of clinical experiments

  1987cited by this paper
• Production of cytotoxin by clinical strains of Pseudomonas aeruginosa.

  1987cited by this paper
• The contribution of exoproducts to virulence of Pseudomonas aeruginosa.

  1986cited by this paper
• The contribution of exoproducts to virulence of Pseudomonas aeruginosa

  1985cited by this paper
• Enzyme-linked immunosorbent assay for detection of antibodies toPseudomonas aeruginosa exoproteins

  1985cited by this paper
• Structure and functions of Pseudomonas aeruginosa lipopolysaccharide.

  1985cited by this paper
• The virulence of Pseudomonas aeruginosa.

  1984cited by this paper
• Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.

  1984cited by this paper
• Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa

  1984cited by this paper
• Immunogenicity of Pseudomonas aeruginosa outer membrane antigens examined by crossed immunoelectrophoresis

  1983cited by this paper
• Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans.

  1983cited by this paper
• Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis

  1983cited by this paper
• Pseudomonas aeruginosa elastase and its role in pseudomonas infections.

  1983cited by this paper
• Phospholipase C (heat-labile hemolysin) of Pseudomonas aeruginosa: purification and preliminary characterization

  1982cited by this paper
• Purification of a cytotoxic protein from Pseudomonas aeruginosa.

  1979cited by this paper
• Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man.

  1979influential reference
• Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyltransferase distinct from toxin A.

  1978cited by this paper
• Pseudomonas aeruginosa bacteremia: a clinical study of 75 patients

  1977cited by this paper
• Exotoxin production by clinical isolates of pseudomonas aeruginosa

  1977cited by this paper
• Improved techniques for the preparation of bacterial lipopolysaccharides.

  1976cited by this paper
• Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection

  1976cited by this paper
• Studies of lipopolysaccharides from Pseudomonas aeruginosa.

  1975cited by this paper
• NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin,.

  1975cited by this paper
• A new method for the extraction of R lipopolysaccharides.

  1969cited by this paper
• New Immunotype Schema for Pseudomonas aeruginosa Based on Protective Antigens

  1969cited by this paper
• Bacterial lipopolysaccharides : extraction with phenol-water and further applications of the procedure

  1965cited by this paper

• Topical p38 MAPK inhibition reduces bacterial growth in an in vivo burn wound model.

  2007cites this paper
• Topical p38 MAPK Inhibition Reduces Bacterial Growth on Burn Wounds in an in vivo Burn Model

  2007cites this paper
• Traitement et pronostic des bactériémies à Pseudomonas aeruginosa

  2004cites this paper
• The role of exotoxin A in the pathogenesis of Pseudomonas aeruginosa burn wound infection

  2001cites this paper
• Untersuchungen zum Postantibiotischen Effekt bei Pseudomonas aeruginosa-Isolaten einer Intensivstation

  1999cites this paper